BRN Discussion Ongoing

[buena suerte :-)]

Morning Chippers....... GREEN everywhere in US, Europe & Asia! Lets hope we follow suit!

Not long to wait now for the 4C !!! ???????????

SYMBOL	PRICE	CHANGE	%CHANGE
DJIA	33,629.56	+254.07	+0.76
NASDAQ	11,364.41	+223.98	+2.01
S&P 500	4,019.81	+47.2	+1.19

​

Stock Indexes​

SYMBOL	PRICE	CHANGE	%CHANGE
*SHANGHAI	3,264.81	+24.53	+0.76
*NIKKEI	26,906.04	UNCH	UNCH
*HSI	22,044.65	+393.67	+1.82
*SHENZHEN	11,980.62	+67.36	+0.56
*KOSPI	2,395.26	+14.92	+0.63
*ASX 200	7,457.3	UNCH	UNCH
*NIFTY 50	18,118.55	+90.9	+0.5
*STI	3,293.71	+17.53	+0.54
*SGX-CNBC CHINA GROWTH	1,473.26	+0.08	+0.01
*CNBC 100	8,645.03	+36.64	+0.43
NZX 50	11,974.17	+25.45	+0.21
*.SETI	1,684.04	+6.79	+0.4
*MALAYSIA	1,500.33	+4.11	+0.27
*TAIWAN	14,932.93	+5.92	+0.0

​

​

Stock Indexes​

SYMBOL	PRICE	CHANGE	%CHANGE
*FTSE	7,784.67	+14.08	+0.18
*DAX	15,102.95	+69.39	+0.46
*CAC	7,032.02	+36.03	+0.52
*STOXX600	454.49	+2.37	+0.52
*AEX	747.87	+9.23	+1.25
*BEL 20	3,889.84	+28.39	+0.74
*FTSE MIB	25,821.45	+45.93	+0.18
OMXS30	2,224.53	+27.11	+1.23
*SMI	11,406.27	+111.25	+0.98
HEX	11,232.18	+80.2	+0.72
*PSI20	5,972.56	+58.75	+0.99
OMXC 25	1,729.49	+6.63	+0.38
*RUSSIA	2,185.31	+18.62	+0.86

 

[Damo4]

At first I was confused by the name of this handle but dont think our resident wordsmith here has a twitter account.

Oooft.
Feels good to be on Mercedes' side.
Imagine becoming market leading in the automotive industry.
We've seen what it did to the TSLA sp

 

[Bravo]

I may be wrong , but I don’t remember coming across this on nViso’s website before specifically mentioning PainChek.


View attachment 27810

Great spotting @TopCat! The NVISO presentation from 2018 says once embedded into intelligent applications they can run on mobile phones. Bearing in mind that was 2018, so in terms of advancements in this area, imagine when AKIDA is embedded into an actual smartphone, how may different applications like this one could be accessible to everyone.

 

[MDhere]

I think something that is missed along the way is that we have agreements with Renesas and Megachips.
Our EAP's may well be signing (I would think most likely) with these companies. We may never see any of them sign an IP licence with BRN!
We may know nothing until royalties start coming in!
I vaguely remember (not quoting) Sean Hehir saying something about watching for income rather than anything else.

Exactly right Shadow, Megachips equals Mega business -
I submit Exhibit A which was buried
Note: early commecialisation focusing on Edge AI through collaboration with Partner Companies - Strategiv partnership... Brainchip
Note note: Mass Production Mid next FY

 

[equanimous]

Oooft.
Feels good to be on Mercedes' side.
Imagine becoming market leading in the automotive industry.
We've seen what it did to the TSLA sp

Mercedes 1200 Km range > Tesla 652 km range

This is really amazing and to think this is the first version of EQXX. What will the 2nd and 3rd version achieve? What will AKida 2.0 be able to achieve?

 

[supersonic001]

AI is coming for white-collar jobs, Gates warns

Billionaire Bill Gates is impressed with generative AI such as ChatGPT, and he isn’t shying away from its capacity to replace some jobs.

www.afr.com

Bring it ….. hmmmmm …

 

[skutza]

Great spotting @TopCat!


View attachment 27813

View attachment 27816

I could be wrong, but I don't believe Painchek use Akida. They have their own AI and I feel that is their selling point. I asked Philip Daffas (CEO PCK) this some time back without a response. I think AKIDA could help them with their one shot learning, as in patient ID would be very quick and also on chip rather than the possible data breach. (Med companies have a problem with this at the moment) but I don't think there is anything there currently. IMO.

 

[buena suerte :-)]

Mercedes 1200 Km range > Tesla 652 km range

This is really amazing and to think this is the first version of EQXX. What will the 2nd and 3rd version achieve? What will AKida 2.0 be able to achieve?

Absolutely! ...... Akida1.0 has already given us the power to be, 'The world’s first commercial producer of neuromorphic AI IP, and
With every New addition to the Akida Family the more our power and dominance will increase!!

BrainChip is the antidote to more. To more devices. More data. More demands on the data center.
Our technology brings commonsense to the processing of sensor data, freeing machines to do more with less, enabling them to infer the big picture from the basics.

"Great to be a shareholder" (@Learning)

GO BRN

 

[Bravo]

I could be wrong, but I don't believe Painchek use Akida. They have their own AI and I feel that is their selling point. I asked Philip Daffas (CEO PCK) this some time back without a response. I think AKIDA could help them with their one shot learning, as in patient ID would be very quick and also on chip rather than the possible data breach. (Med companies have a problem with this at the moment) but I don't think there is anything there currently. IMO.

Pretty sure they'de be utilizing NVISO SDK (software development kit). In January at CES NVISO did a demo with AKIDA running on the latest NVISO SDK.

 

[buena suerte :-)]

Looking much better this morning!

The spiritual meaning of 666 is an encouragement to refocus

666 buyers for 9,210,240 units
419 sellers for 5,592,933 units

 

[Bravo]

Looking much better this morning!

The spiritual meaning of 666 is an encouragement to refocus

666 buyers for 9,210,240 units
419 sellers for 5,592,933 units

The number the beast!

 

[Bravo]

It's great to have Arm as a partner!

https://www.businessweekly.co.uk/news/hi-tech/sea-rescue-robot-powered-arm-technology

 

[BaconLover]

I could be wrong, but I don't believe Painchek use Akida. They have their own AI and I feel that is their selling point. I asked Philip Daffas (CEO PCK) this some time back without a response. I think AKIDA could help them with their one shot learning, as in patient ID would be very quick and also on chip rather than the possible data breach. (Med companies have a problem with this at the moment) but I don't think there is anything there currently. IMO.

"I asked Philip Daffas (CEO PCK) this some time back without a response".



This is no coincidence.
Whenever there are questions that make people feel uncomfortable they don't respond.

If it's a no, they usually say "no, we aren't using Akida".

I'm not saying they're using Akida, but interesting he didn't respond at all.

 

[skutza]

"I asked Philip Daffas (CEO PCK) this some time back without a response".



This is no coincidence.
Whenever there are questions that make people feel uncomfortable they don't respond.

If it's a no, they usually say "no, we aren't using Akida".

I'm not saying they're using Akida, but interesting he didn't respond at all.

Yes everything is possible. However they've been running their app now for many years and while they may well add to their app to make it better, they do use their own AI currently. I always thought it would be a perfect addition to their IP but they don't make money currently so may be reluctant to add more costs. But you gotta spend money to make money!

 

[Bravo]

Nice find. It doesn’t have to mean anything more than Tenstorrent is just using RISC-V architecture from SiFive, but I wonder if Jim Keller knows about Akida

Hopefully ! Judging from this extract (below), it looks like Jim Keller is aware of the significance of edge computing and sensors that do pre-processing which "naturally interfaces with the rest of this model".

BrainChip and SiFive Partner to Deploy AI/ML Technology at the Edge​

BrainChip and SiFive partner to combined their respective technologies to offer chip designers optimized AI/ML compute at the edge.

brainchip.com
“Employing Akida, BrainChip’s specialized, differentiated AI engine, with high-performance RISC-V processors such as the SiFive Intelligence Series is a natural choice for companies looking to seamlessly integrate an optimized processor to dedicated ML accelerators that are a must for the demanding requirements of edge AI computing,” said Chris Jones, vice president, products at SiFive. “BrainChip is a valuable addition to our ecosystem portfolio”.

Tenstorrent Blackhole, Grendel, And Buda - A Scale Out Architecture For Sparsity, Conditional Execution, And Dynamic Routing

Tenstorrent have made some very large claims about the future of neural network model architectures, issues with edge versus datacenter, hardware performance / efficiency, and software prowess. In this article, we dive into these claims as well as their next generation hardware, Blackhole and...

www.semianalysis.com

 

[Diogenese]

Yes everything is possible. However they've been running their app now for many years and while they may well add to their app to make it better, they do use their own AI currently. I always thought it would be a perfect addition to their IP but they don't make money currently so may be reluctant to add more costs. But you gotta spend money to make money!

This is the Painchek patent:
US10398372B2 Pain assessment method and system

Applicants EPAT PTY LTD [AU]
​

Inventors HUGHES JEFF [AU]; HOTI KRESHNIK [AU]; ATEE MUSTAFA ABDUL WAHED [AU]
​

1. A method for determining an effect of a drug on pain experienced by a patient, the method comprising:
using a camera to capture positional information of at least one visible facial feature from the patient;
comparing, using a processor of a pain assessment system, the positional information of the at least one visible facial feature to predetermined data for the at least one visible facial feature to determine reference information that is indicative of a reference level of the pain experienced by the patient;
after administering the drug to the patient using the camera to capture second information indicative of the at least one visible facial feature from the patient;
comparing, using the processor, the second information to the predetermined data for the at least one visible facial feature to determine pain indicating information associated with a level of pain experienced by the patient after administering the drug to the patient;
comparing, using the processor, the pain indicating information with the reference information to determine the effect of the drug on the pain experienced by the patient; and
providing an alternative treatment to the patient for the pain experienced by the patient in response to determining that the effect of the drug is below a predetermined threshold.
...
9. A pain assessment system comprising:

an interface for receiving positional information concerning at least one visible facial feature that is indicative of a reference level of pain, and for receiving second information indicative of the at least one visible facial feature of a patient after administering a drug to the patient, the at least one visible facial feature being capable of indicating a pain level experienced by the patient, wherein the positional information and second information indicative of at least one visible facial feature of the patient are captured using a camera; and

a processor arranged to:

compare the positional information to predetermined data for the at least one visible facial feature to determine reference information that is indicative of the reference level of the pain experienced by the patient,

compare the received second information to the predetermined data for the at least one visible facial feature to determine pain indicating information associated with a level of pain experienced by the patient,

compare the determined pain indicating information with the reference information such that an effect of the drug on the pain experienced by the patient can be determined, and

determine an alternative treatment to the patient based on the determined effect of the drug on the pain experienced by the patient being below a predetermined threshold.

As you say, Painchek do not have the cash to invest in hardware, nor do they have a pressing need to do so.

 

[Bravo]

This is the Painchek patent:
US10398372B2 Pain assessment method and system

Applicants EPAT PTY LTD [AU]​

​

Inventors HUGHES JEFF [AU]; HOTI KRESHNIK [AU]; ATEE MUSTAFA ABDUL WAHED [AU]​

​

View attachment 27837

View attachment 27836
1. A method for determining an effect of a drug on pain experienced by a patient, the method comprising:
using a camera to capture positional information of at least one visible facial feature from the patient;
comparing, using a processor of a pain assessment system, the positional information of the at least one visible facial feature to predetermined data for the at least one visible facial feature to determine reference information that is indicative of a reference level of the pain experienced by the patient;
after administering the drug to the patient using the camera to capture second information indicative of the at least one visible facial feature from the patient;
comparing, using the processor, the second information to the predetermined data for the at least one visible facial feature to determine pain indicating information associated with a level of pain experienced by the patient after administering the drug to the patient;
comparing, using the processor, the pain indicating information with the reference information to determine the effect of the drug on the pain experienced by the patient; and
providing an alternative treatment to the patient for the pain experienced by the patient in response to determining that the effect of the drug is below a predetermined threshold.
...
9. A pain assessment system comprising:

an interface for receiving positional information concerning at least one visible facial feature that is indicative of a reference level of pain, and for receiving second information indicative of the at least one visible facial feature of a patient after administering a drug to the patient, the at least one visible facial feature being capable of indicating a pain level experienced by the patient, wherein the positional information and second information indicative of at least one visible facial feature of the patient are captured using a camera; and

a processor arranged to:

compare the positional information to predetermined data for the at least one visible facial feature to determine reference information that is indicative of the reference level of the pain experienced by the patient,

compare the received second information to the predetermined data for the at least one visible facial feature to determine pain indicating information associated with a level of pain experienced by the patient,

compare the determined pain indicating information with the reference information such that an effect of the drug on the pain experienced by the patient can be determined, and

determine an alternative treatment to the patient based on the determined effect of the drug on the pain experienced by the patient being below a predetermined threshold.

As you say, Painchek do not have the cash to invest in hardware, nor do they have a pressing need to do so.

Here's an article from 2019 which shows the connection between PainCheck's inventors Hoti, Hughes, Mustafa and NVISO.

My parents were going to call me Hoti but they settled on Bravo instead.

Facing Up to Pain - Medical Forum

mforum.com.au

 

[equanimous]

Here's an article from 2019 which shows the connection between PainCheck's inventors Hoti, Hughes, Mustafa and NVISO. My parents were going to call me Hoti but they settled on Bravo instead.


View attachment 27840

Facing Up to Pain - Medical Forum

mforum.com.au

For some reason I always picture your cat on the computer doing the BRN research

 

[Bravo]

Yes

For some reason I always picture your cat on the computer doing the BRN research

Admittedly I pay him well below the award rates but I make up with it by showering him with cuddles and yummy treats.

 

[TopCat]

Here's an article from 2019 which shows the connection between PainCheck's inventors Hoti, Hughes, Mustafa and NVISO. My parents were going to call me Hoti but they settled on Bravo instead.


View attachment 27840

Facing Up to Pain - Medical Forum

mforum.com.au

This is pure speculation on my behalf, but they recently did a cash raise to pay for, amongst other things, a “ core technology upgrade “